… discovery of new therapies against COVID-19. In this article, … regarding efficacy of repurposed
drugs against COVID-19 and … COVID-19 epidemiology, and then have discussed drug …

… of these newly developed drugs on COVID-19. Experience with previous virus pandemics
has shown us that developing an ample repertoire of antiviral drugs with different targets will …

… mortality in patients with severe COVID-19. In addition, convalescent plasma … COVID-19.
There is currently no single worldwide approved therapeutic option for patients with COVID-19 …

… drugs have been approved for the treatment of COVID-19. This study aimed to evaluate the
efficacy of favipiravir in treatment of COVID-19. … promising drug for treatment of COVID-19 that …

… The experimental antiviral drug remdesivir (manufactured by Gilead) was granted … US Food
and Drug Administration in May 2020 for patients hospitalized with severe COVID-19. At the …

… of the COVID-19 outbreak, several drugs … COVID-19 vaccine will decree the death of the
drugs repurposing era? It seems unlikely. Drug repurposing is the evaluation of existing drugs …

… In the United States, the most promising drug therapy thus far has been remdesivir (GS-…
and Drug Administration to allow emergency use access of the drug for COVID-19 treatment on …

… efficacy in treating COVID-19. However, its emergence has also led to a large number of
clinical trials evaluating drug … to move beyond traditional drug screening and repurposing by …

… In recent past, out of the all drug therapies explored for combating COVID-19, antivirals
exhibited promising results. Some of them are tested due to their earlier beneficial role against …

… COVID-19; most of them are undergoing clinical trials. This article summarizes clinical
investigations of potential therapeutic drugs used as COVID-19 … , covid-19 antiviral drugs' efficacy …